title: Drug interactions between warfarin and efavirenz or lopinavir-ritonavir in clinical treatment.
authors.forename: Stefano
authors.initials: S
authors.lastname: Bonora
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Lanzafame
authors.forename: Antonio
authors.initials: A
authors.lastname: D'Avolio
authors.forename: Laura
authors.initials: L
authors.lastname: Trentini
authors.forename: Emanuela
authors.initials: E
authors.lastname: Lattuada
authors.forename: Ercole
authors.initials: E
authors.lastname: Concia
authors.forename: Giovanni
authors.initials: G
authors.lastname: Di Perri
mesh_terms: D000328:Adult; D000368:Aged; D000480:Alkynes; D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism; D048588:Benzoxazines / Q000494:pharmacology*; D003521:Cyclopropanes; D065729:Cytochrome P-450 CYP2C9; D004347:Drug Interactions; D005260:Female; D006801:Humans; D061466:Lopinavir; D008297:Male; D011744:Pyrimidinones / Q000494:pharmacology*; D019438:Ritonavir / Q000494:pharmacology*; D014859:Warfarin / Q000493:pharmacokinetics / Q000494:pharmacology*
chemical_list: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D011744:Pyrimidinones; D061466:Lopinavir; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; C098320:efavirenz; D019438:Ritonavir